When Traditional Treatments Fail,
Ketamine Offers a New Path

What is diagnosed anxiety?

Anxiety-related conditions can affect every aspect of daily life, from relationships and work performance to sleep, confidence, and emotional well-being. Disorders such as Generalized Anxiety Disorder (GAD), Social Anxiety, Mixed Anxiety and Depression, and Obsessive-Compulsive Disorder (OCD) often involve persistent worry, racing thoughts, emotional overwhelm, or repetitive thought patterns that can feel difficult to control. For individuals who have not found adequate relief through traditional approaches alone, ketamine therapy may offer a promising, research-supported option to help reduce symptoms, improve emotional resilience, and support a greater sense of calm and balance.

Understanding the Differences Between TRD, MDD, and Bipolar Disorder

While these conditions can share symptoms such as sadness, low energy, difficulty concentrating, and loss of interest in daily life, they differ in important ways that affect diagnosis and treatment planning.

Major Depressive Disorder (MDD)

is characterized by persistent depression symptoms that may include hopelessness, fatigue, changes in sleep or appetite, low motivation, and emotional heaviness lasting for at least two weeks or longer. Individuals with MDD experience depressive episodes without periods of mania or unusually elevated mood.

Treatment-Resistant Depression (TRD)

is not a separate diagnosis, but rather a form of depression in which symptoms continue despite trying multiple standard treatments such as antidepressant medications or therapy. A person with TRD may still meet criteria for MDD, but their depression has proven more difficult to successfully treat through traditional methods alone.

Bipolar Disorder

involves cycles of depression along with periods of elevated mood or increased energy known as mania or hypomania. During these periods, individuals may experience racing thoughts, impulsivity, reduced need for sleep, increased confidence, irritability, or unusually high energy levels. Because bipolar depression can sometimes resemble MDD, a thorough mental health evaluation is important to ensure accurate diagnosis and appropriate treatment. Ther is a risk of increased mania associated with Ketamine therapy which can affect treatment outcomes.

Ketamine (Intravenous Ketamine)

IV ketamine is administered directly into the bloodstream through an intravenous infusion, allowing for highly controlled dosing and rapid absorption. Because the medication bypasses digestion and enters circulation immediately, IV ketamine is considered the most bioavailable and precisely adjustable form of treatment. It is commonly used for Treatment-Resistant Depression (TRD), PTSD, anxiety disorders, chronic pain conditions, and acute suicidal ideation. IV infusions are often referenced in treatment plans as an “induction series” or “loading phase,” typically involving multiple sessions over several weeks followed by maintenance or booster infusions as needed.

How These Treatments May Be Referenced in a Treatment Plan

Ketamine treatment plans are often individualized and may include terms such as:

Induction Phase

Initial series of treatments designed to build symptom relief

Maintenance Therapy

Ongoing treatments intended to sustain progress

Booster Sessions

Periodic treatments provided when symptoms begin to return

Adjunctive Therapy

Ketamine used alongside psychotherapy, medications, lifestyle interventions, or wellness support

Integration Support

Therapeutic practices designed to help patients process emotional insights and reinforce long-term healing after treatment sessions

Because every patient responds differently, treatment frequency, dosing approach, and maintenance needs may vary over time based on symptom severity, diagnosis, overall health, and therapeutic goals.

Who May Not Be a Good Candidate for Ketamine?

Ketamine therapy for conditions such as Major Depressive Disorder (MDD), Treatment-Resistant Depression (TRD), and Bipolar Depression may not be suitable for every patient. Individuals with active psychosis, schizophrenia, uncontrolled bipolar mania, severe uncontrolled hypertension, significant cardiovascular disease, or active substance misuse may be at higher risk for adverse effects or symptom worsening during treatment. Because ketamine can temporarily alter perception, mood, and blood pressure, careful monitoring is necessary for patients with complex psychiatric or medical histories. In bipolar disorder specifically, ketamine must be used cautiously, as some individuals may be vulnerable to triggering manic or hypomanic symptoms if mood stabilization is not adequately addressed. Patients who are pregnant, medically unstable, or unable to participate safely in the treatment process may also require alternative approaches or additional medical clearance prior to treatment.

Important Considerations.

Hormonal imbalances, vitamin deficiencies, inflammation, sleep disturbances, thyroid dysfunction, and other underlying health conditions can all influence both mood symptoms and the effectiveness of ketamine therapy. Factors such as low vitamin D, B12 deficiency, anemia, chronic stress, poor nutrition, or imbalanced hormones like cortisol, estrogen, progesterone, or testosterone may contribute to depression, fatigue, anxiety, and emotional instability. Addressing these underlying contributors alongside ketamine therapy can help support a more complete and lasting response to treatment. For this reason, many providers recommend a comprehensive wellness approach that may include lab testing, primary care follow-up, lifestyle support, and ongoing mental health care to optimize overall outcomes.

How can you help your success?

Successful ketamine treatment is often supported by an active commitment to overall mental and physical wellness throughout the healing process. Patients may improve their outcomes by maintaining healthy sleep habits, proper nutrition, hydration, regular movement, stress management, therapy participation, and honest communication with their care team. Journaling, mindfulness practices, emotional integration work, and reducing alcohol or substance use can also help reinforce the benefits of treatment. 

Because every individual responds differently, maintenance may include periodic booster sessions, continued psychotherapy, medication management, lifestyle changes, or ongoing wellness support designed to help sustain emotional balance and long-term symptom relief.

References Supporting Ketamine Therapy for Depression

  1. McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. American Journal of Psychiatry. 2021.
  2. U.S. Food & Drug Administration (FDA). FDA Approval of Spravato (Esketamine) for Treatment-Resistant Depression. 2019.
  3. Veterans Affairs (VA) Community Care. Intranasal Esketamine for Treatment-Resistant Depression Clinical Guidance.
  4. American Psychiatric Association (APA). Guidelines and Clinical Research on Ketamine and Esketamine for Depression.
  5. Correia-Melo FS, Leal GC, Vieira F, et al. Efficacy and Safety of Ketamine in Major Depressive Disorder and Treatment-Resistant Depression. Current Neuropharmacology.
  6. Zarate CA Jr., Singh JB, Carlson PJ, et al. A Randomized Trial of an N-Methyl-D-Aspartate Antagonist in Treatment-Resistant Major Depression. Archives of General Psychiatry. 2006.
  7. Wilkinson ST, Ballard ED, Bloch MH, et al. The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Meta-Analysis. American Journal of Psychiatry.
  8. National Institutes of Health (NIH). Ketamine and Esketamine Research in Depression and Mood Disorders.
  9. Harvard Medical School / Mass General Brigham. Research Comparing IV Ketamine and Esketamine for Severe Depression.
  10. Feder A, Parides MK, Murrough JW, et al. Efficacy of Intravenous Ketamine for Treatment of Chronic PTSD and Depression Symptoms. JAMA Psychiatry.